Two distinct subtypes of human rotavirus serotype 4 were identified by using neutralizing monoclonal antibodies directed to the major outer capsid glycoprotein, VP7, of strains ST3 (subtype 4A) and VA70 (subtype 4B). Specimens containing serotype 4 rotavirus, obtained from different countries, were examined for subtyping by using solid-phase immune electron microscopy, enzyme-linked immunosorbent assay, and, for cell culture-adapted strains, neutralization assay. All 59 human rotavirus strains identified as serotype 4 by using animal antisera were classified into either subtype by monoclonal antibodies. This suggests that the antigenic difference between the two subtypes is a consequence of critical variations within the immunodominant serotype 4-specific neutralization site of rotavirus VP7. Subtype 4A (ST3-like) strains were predominant and were detected in stools from patients with gastroenteritis, as well as from healthy infants and young children.
cause of acute nonbacterial gastroenteritis in infants and young children, are classified into four distinct serotypes on the basis of their specific reactivity with animal hyperimmune sera in neutralization (NT) assays (12) . In the last few years, two presumptive new HRV serotypes have been identified in cross-NT assays (1, 3, 15) . The rotavirus classification proposed by Hoshino et al. (12) , which has been widely accepted, included HRV serotypes 1 to 4, porcine rotavirus (OSU strain) as serotype 5, bovine rotavirus as serotype 6, and avian rotavirus as serotype 7. The two new distinct HRV serotypes, once confirmed as such, will possibly be classified as serotypes 8 and 9. The major antigen responsible for rotavirus serotype specificity was believed to be the outer capsid glycoprotein VP7, the eighth or ninth gene product (10, 13, 16, 18) . However, recently the outer capsid protein VP3, coded for by the fourth rotavirus gene, was shown to be capable of eliciting neutralizing antibody at a level as high as that elicited by VP7 (1, 17) . Thus, in the future a better definition of rotavirus serotypes should include designation of both VP3 and VP7 specificities.
In 1985, using cross-absorbed animal polyclonal immune sera and the solid-phase immune electron microscopy (SPIEM) technique, we identified two distinct subtypes within serotype 4 HRV strains (8) . The two reference strains, ST3 (subtype 4A) and VA70 (subtype 4B), both appeared to be serotype 4 by NT assay but were clearly differentiated by SPIEM, and all serotype 4 HRV strains were classified into either subtype. However, after absorption with all heterotypes, ST3 antiserum was reactive with both subtypes, whereas VA70 antiserum was highly subtype specific. In the present study, by using neutralizing mouse monoclonal antibodies (MAbs) specific to VP7 of either ST3 or VA70, the two subtypes of serotype 4 HRV have definitely been identified by enzyme-linked immunosorbent assay (ELISA), SPIEM, and, for cell culture-adapted strains, NT, thus suggesting that critical variations between the two Corresponding author.
subtypes occur within the immunodominant serotype 4-specific NT site of VP7.
MATERIALS AND METHODS
Rotavirus strains. Cell culture-adapted rotavirus strains DS-1, Wa, and ST3 were kindly provided by R. G. Wyatt, National Institute of Allergy and Infectious Diseases, Bethesda, Md. Strain YO was supplied by S. Urasawa, University of Sapporo, Sapporo, Japan. Strains VA70, VA75, VA79, PV5249, and PV5257 were previously adapted to growth on cell cultures in our laboratory (7) . All strains were propagated on MA104 cell cultures in the presence of trypsin (7).
Antisera. Immune sera against reference HRV serotypes DS-1, Wa, YO, ST3, and VA70 and several other cell culture-adapted HRV strains were prepared in our laboratory by immunizing rabbits and guinea pigs, free of rotavirus antibody, with partially purified virus (7) . For use in the SPIEM assay, sera from immunized animals were made type specific by sequential absorption steps (8) . Briefly, each antiserum was first absorbed with single-shelled rotavirus particles of subgroups I and II and then with a mixture of double-shelled virus particles of the three heterotypes. After a final centrifugation at 140,000 x g for 90 min to pellet the virus, absorbed sera were suitable for typing, i.e., free of group, subgroup, and heterotypic reactivity.
Murine MAbs. Rotavirus type-specific neutralizing MAbs RV-4:2 (anti-serotype 1), RV-5:3 (anti-serotype 2), RV-3:1 (anti-serotype 3), and ST-3:1 (anti-serotype 4) were provided by B. S. Coulson, University of Melbourne, Parkville, Victoria, Australia. Their properties have previously been extensively reported (4, 5) . MAbs to HRV 4B were produced in our laboratory essentially as described for SA11-neutralizing MAbs (8a) but by using BALB/c mice immunized with partially purified VA70 and VA70-like strains. DS-1 (2) 30,000 <1,000
<1,000 <1,000 <1,000
Wa (1) <1,000 10,000 <1,000 <1,000 <1,000 YO (3) <1,000 <1,000 100,000 <1,000 <1,000 ST3 (4A) <1,000 <1,000 <1,000 300,000 1,000 VA70 (4B) <100 <100 <100 <100 30,000
a Titers are expressed as reciprocals. Homologous titers are given in boldface.
suspensions. After negative staining, 20 grid squares were examined for each grid with a Philips EM201 electron microscope at x45,000, and the average number of virus particles per grid square was determined. Typing ratios of rotavirus strains were calculated as described previously (8) .
Serotype 4 HRV strains. A group of 59 serotype 4 HRV strains previously serotyped by NT or SPIEM or both was examined for subtyping. The specimens were from several European countries, North and South America, and Australia. Viral RNA was extracted from some samples and analyzed by polyacrylamide gel electrophoresis for determination of electropherotype (6) .
RESULTS
Subtyping of HRV serotype 4 by using animal antisera. When ST3 and VA70 hyperimmune sera were tested in cross-NT assays, HRV strains ST3 and VA70 appeared to be antigenically different, even though such a difference was not sufficient to define two distinct serotypes, according to established criteria (12) . In SPIEM, after cross-absorption of hyperimmune sera to make them type specific (8), ST3 antiserum strongly reacted with both ST3 and VA70 strains, whereas VA70 antiserum did not appreciably react with ST3 virus. Thus, ST3 could be typed only by homologous antiserum in SPIEM, whereas VA70 was typed by both antisera. However, ST3 immune serum could correctly type many, but not ail, of the VA70-like HRV strains available. (Tables  2 and 3) . ELISA subtyping ratios, calculated for each strain by dividing the absorbance in wells reacted with ST3 MAb by that in the wells reacted with VA70 MAb, were >3.00 for subtype 4A HRVs and between 0.03 and 0.15 for subtype 4B strains.
A few cell culture-adapted HRV strains of serotype 4 were available. By using ST3 and VA70 MAbs, they could be subtyped also by NT. Results of subtyping by NT assay were in agreement with those obtained by SPIEM and ELISA (data not shown).
Prevalence of serotype 4 subtypes. Specimens containing serotype 4 HRVs from several countries were available. Subtype 4A strains were found to circulate in all areas of the three continents from which specimens were collected. Subtype 4B strains were shown to cocirculate with subtype 4A HRVs, but so far they have been found only in Italy and South America (Chile) and in stools from children with diarrhea. On the other hand, subtype 4A HRVs were identified in samples from patients with gastroenteritis as well as from healthy infants and young children. No correlation was found between RNA electropherotypes and subtypes of the HRV serotype 4 strains examined (Fig. 3) .
DISCUSSION
The results obtained in the present study unequivocally demonstrate that serotype 4 HRVs belong to two distinct subtypes: 4A, including ST3-like strains, which represent about 75% of serotype 4 strains; and 4B, including VA70-like strains, which represent about 25% of the serotype 4 HRVs so far examined. All 59 strains identified as serotype 4 by using animal antisera were definitely subtyped by MAbs. Thus, it seems unlikely that the two subtypes are only minor variants within a well-defined serotype. Furthermore, the two MAbs identified the same subtypes recognized, although less clearly, by cross-absorbed antisera in SPIEM (8) . No particular RNA electrophoretic migration pattern was associated with either subtype, in agreement with our previous findings on the electropherotype heterogeniety within HRV serotypes (6) . A small but distinct difference in the electrophoretic mobility of unreduced VP7 was consistently observed between ST3 and VA70, but several HRV strains should be analyzed to define its possible relation with subtypes.
Recently, sequence analysis of the VP7 gene from different rotavirus serotypes identified six major regions, A to F, of amino acid divergence (9) . Regions B (amino acids 87 to 101) and E (amino acids 208 to 221) are thought to represent the immunodominant NT antigenic site of VP7 glycoprotein. Differences of one amino acid substitution in region B and two substitutions in region E were found between ST3 and VA70 strains. Thus, the immunological difference between the two subtypes of HRV serotype 4 might be due to only three amino acid substitutions in the immunodominant NT antigenic site of the VP7 molecule. However, one amino acid substitution at residue 238, where ST3, but not VA70, possesses a potential glycosylation site, might be responsible for the higher electrophoretic mobility of VA70 VP7, as well as for its altered antigenicity (2) . Comparative analyses of the VP7 amino acid sequences of several serotype 4 HRV strains would clarify this point.
Initially, cross-NT assays with animal hyperimmune sera showed that the two prototypes of HRV serotype 4 were antigenically different, but that difference was not sufficient to define two distinct serotypes. After cross-absorption of hyperimmune sera to make them type specific (8) , in the SPIEM system many, but not all, of the VA70-like (subtype 4B) strains were identified as serotype 4 by ST3 antiserum. Some subtype 4B strains were reactive only with VA70 antiserum. This finding made it necessary to use both ST3 and VA70 animal hyperimmune sera for routine typing of HRVs directly in stool specimens. When MAbs to each of the two subtypes became available, we observed that some cross-reactivity was displayed by ST3 MAb by SPIEM, ELISA, and NT assay, whereas VA70 MAb appeared to be highly subtype specific. On the basis of experimental results obtained by both SPIEM and ELISA, the degree of crossreactivity possessed by ST3 MAb is high enough to identify as serotype 4 
